NEWS
- siRNA Therapeutics: Current Status & Delivery System
- Cleavable & Non-Cleavable PEG Linkers for XDCs
- Oligonucleotide Drugs: Current Status and Challenges
- 3D Bioprinting in Disease Prevention & Treatment
- Antibody-drug Conjugates for HER2-Positive Gastric Cancer
- HER3 Targeted Therapies: Monoclonal Antibody, Bispecific Antibody & ADC
- c-MET: A Novel Target for Anticancer Therapies
- Development of PD-L1 Antibody Drug Conjugates (ADC)
- Peptide-Drug Conjugate (PDC) VS Immune Stimulating Antibody Conjugate (ISAC)
- Novel FRα-targeting Antibody-drug Conjugates (ADCs)